Registration Options

Activity Dates: 10/13/2023 - 10/12/2025

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

BCPPs desiring an evidence-based focus on an emerging area of practice and contemporary issues in psychiatric pharmacy at the specialist level are the intended audience of this recertification activity. This activity is designed for BCPPs who learn best from didactic presentations, are auditory and visual learners, and/or who learn best from hands-on-learning and dialoguing with specialist faculty and colleagues.


Session Summary

Patients with severe mental illness usually require long-term treatment with psychotropic medications. Medication non-adherence is problematic in this patient population, which can result in symptom relapse and hospitalization. Long-acting injections (LAIs), whether antipsychotics or novel treatments for alcohol and opioid use disorders, provide a unique approach to treatment of these conditions. LAIs have been shown to improve adherence to treatment, leading to better outcomes. While LAIs are one example, there are other psychotropic medications that can be administered and/or monitored by pharmacists, such as esketamine and buprenorphine. Administering medications routinely in clinics, particularly primary care clinics can be challenging. Challenges include provider education, logistical aspects to care, and concerns about adverse effects and monitoring. This presentation will discuss how pharmacists are in a key position to help overcome these barriers by providing education, implementing logistical policies and billing procedures, and administering and monitoring psychotropic medications.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Alberto Augsten, PharmD, MS, BCPP, DABAT

View biographical information and disclosures

Learning Objectives

  1. Outline psychiatric medications which can be managed or administered by a pharmacist.
  2. Create a safety and efficacy monitoring plan for psychiatric medications administered or managed by a pharmacist in an outpatient setting.
  3. Assess the role of the pharmacist in psychiatric medication administration or management in the outpatient setting.

Continuing Education Credit and Disclosures

Activity Dates: 10/13/2023 - 10/12/2025
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-23-013-H04-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.